Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

HER-2 A775_G776insYVMA

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

HER-2 fusion (1)

HER-2 fusion (1)

›

HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	rivoceranib + pyrotinib Sensitive: C3 – Early Trials rivoceranib + pyrotinib Sensitive : C3	rivoceranib + pyrotinib Sensitive: C3 – Early Trials rivoceranib + pyrotinib Sensitive : C3
HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3	afatinib Sensitive: C3 – Early Trials afatinib Sensitive : C3
HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	pyrotinib Sensitive: C3 – Early Trials pyrotinib Sensitive : C3	pyrotinib Sensitive: C3 – Early Trials pyrotinib Sensitive : C3
HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	dacomitinib Sensitive: C3 – Early Trials dacomitinib Sensitive : C3	dacomitinib Sensitive: C3 – Early Trials dacomitinib Sensitive : C3
HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	ado-trastuzumab emtansine Sensitive: C3 – Early Trials ado-trastuzumab emtansine Sensitive : C3	ado-trastuzumab emtansine Sensitive: C3 – Early Trials ado-trastuzumab emtansine Sensitive : C3
HER-2 A775_G776insYVMA	Lung Adenocarcinoma	HER-2 A775_G776insYVMA	Lung Adenocarcinoma	tarloxotinib bromide Sensitive: C4 – Case Studies tarloxotinib bromide Sensitive : C4	tarloxotinib bromide Sensitive: C4 – Case Studies tarloxotinib bromide Sensitive : C4
HER-2 A775_G776insYVMA	Lung Adenocarcinoma	HER-2 A775_G776insYVMA	Lung Adenocarcinoma	ado-trastuzumab emtansine Sensitive: C4 – Case Studies ado-trastuzumab emtansine Sensitive : C4	ado-trastuzumab emtansine Sensitive: C4 – Case Studies ado-trastuzumab emtansine Sensitive : C4
HER-2 A775_G776insYVMA	Lung Adenocarcinoma	HER-2 A775_G776insYVMA	Lung Adenocarcinoma	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4
HER-2 A775_G776insYVMA	Lung Adenocarcinoma	HER-2 A775_G776insYVMA	Lung Adenocarcinoma	pyrotinib Sensitive: D – Preclinical pyrotinib Sensitive : D	pyrotinib Sensitive: D – Preclinical pyrotinib Sensitive : D
HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	HER-2 A775_G776insYVMA	Non Small Cell Lung Cancer	mobocertinib Sensitive: D – Preclinical mobocertinib Sensitive : D	mobocertinib Sensitive: D – Preclinical mobocertinib Sensitive : D